Analyst Reco. Evolus, Inc.

Equities

EOLS

US30052C1071

Market Closed - Nasdaq Other stock markets 16:00:00 2024-04-26 EDT			5-day change	1st Jan Change
11.43 ^USD	-0.26%		-0.87%	+8.55%

04-26	AbbVie raises annual profit forecast on strong Skyrizi sales	RE
04-17	Evolus, Inc. Announces Publication of Safety and Duration Data from Phase 2 Study for "Extra- Strength" 40U Formulation of Jeuveau	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Evolus Insider Sold Shares Worth $1,344,604, According to a Recent SEC Filing	03-22	MT
Mizuho Securities Adjusts Evolus Price Target to $23 From $20, Maintains Buy Rating	03-08	MT
Barclays Upgrades Evolus to Overweight From Equalweight, Raises Price Target to $16 From $10	01-29	MT
HC Wainwright Adjusts Price Target on Evolus to $27 From $16, Maintains Buy Rating	23-08-03	MT
Mizuho Securities Adjusts Evolus Price Target to $20 From $17, Maintains Buy Rating	23-06-07	MT
Truist Securities Adjusts Price Target on Evolus to $18 From $14, Maintains Buy Rating	23-05-26	MT
HC Wainwright Adjusts Price Target on Evolus to $16 From $15, Maintains Buy Rating	23-05-10	MT
Mizuho Securities Adjusts Evolus' Price Target to $17 From $15, Keeps Buy Rating	23-01-19	MT
Needham & Co Initiates Coverage on Evolus With Buy Rating, $18 Price Target	22-06-23	MT
Barclays Upgrades Evolus to Equalweight From Underweight, Adjusts Price Target to $10 From $8	22-05-12	MT
Truist Securities Upgrades Evolus to Buy From Hold; Price Target is $11	22-01-20	MT
HC Wainwright Adjusts Evolus' Price Target to $15 From $22, Keeps Buy Rating	21-11-03	MT
EVOLUS : Barclays Adjusts Evolus' Price Target to $7 From $8, Maintains Underweight Rating	21-05-13	MT
EVOLUS : Mizuho Securities Upgrades Evolus to Buy From Neutral; Price Target is $15	21-05-06	MT
EVOLUS : HC Wainwright Adjusts Evolus' Price Target to $22 From $20, Maintains Buy Rating	21-04-08	MT
EVOLUS : Mizuho Adjusts Evolus' Price Target to $15 From $9, Maintains Neutral Rating	21-03-30	MT
EVOLUS : HC Wainwright Adjusts Evolus' Price Target to $20 From $18, Maintains Buy Rating	21-03-24	MT
EVOLUS : Truist Securities Downgrades Evolus to Hold From Buy, Adjusts Price Target to $12 From $6	21-02-24	MT
EVOLUS : Barclays Adjusts Evolus' Price Target to $8 From $4, Reiterates Underweight Rating	21-02-22	MT
EVOLUS : Mizuho Adjusts Evolus' Price Target to $9 From $5, Maintains Neutral Rating	21-02-22	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Evolus, Inc.

Equities

EOLS

US30052C1071

Analyst Reco.

Filters